Mkt-077: Antineoplastic

Drugs of the Future

Volumn 23, Issue 1, 1998, Pages 24-27

  Wrobleski, T ^a   Graul, A ^a   Castaner J ^a  

^a PROUS SCIENCE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CATIONIC RHODACYANINE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CYTOTOXICITY; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MITOCHONDRIAL RESPIRATION; NONHUMAN;

EID: 0031887395     PISSN: 03778282     EISSN: None     Source Type: Journal    
DOI: 10.1358/dof.1998.023.01.442868     Document Type: Article

References (22)

1. Kawakami, M., Koya, K., Ukai, T., Tatsuta, N., Ikegawa, A., Ogawa, K., Shishido, T., Chen, L.B. Structure-activity of novel rhodacyanine dyes as antitumor agents. J Med Chem 1998, 41: 130-42.
2. Shishido, T., Lan, B. (Dana-Farber Cancer Inst.; Fuji Photo Film Co., Ltd.). Compsn. and method for treating cancer. EP 527494, US 5360803.
3. Chen, L.B. Mitochondria membrane potential in living cells. Annu Rev Cell Biol 1988, 4: 155-81.
4. Lampids, T.J., Bernal, S.D., Summerhayes, I.C., Chen, L.B. Selective toxicity of rhodamine-123 in carcinoma cells in vitro. Cancer Res 1983, 43: 716-20.
5. Nadakavukaren, K.K., Nadakavukaren, J.J., Chen, L.B. Increased rhodamine-123 uptake by carcinoma cells. Cancer Res 1985, 45: 6093-9.
6. Anderson, W.M., Delinck, D.L., Benniner, L., Wood, J.M., Smiley, S.T., Chen, L.B. Cytotoxic effect of thiacarbocyanine dyes on human colon carcinoma cell and inhibition of bovine heart mitochondrial NADH - Ubiquinone reductase activity via a rotenone-type mechanism by two of the dyes. Biochem Pharmacol 1993, 45: 691-6.
7. Sun, X., Wong, J.R., Song, K., Hu, J., Garlid, K.D., Chen, L.B. AA-1, a newly synthesized monovalent lipophilic cation expresses potent in vivo antitumor activity. Cancer Res 1994, 54: 1465-71.
8. Modica-Napolitano, J.S., Aprille, J.R. Basis for the selective-cytotoxicity of rhodamine 123. Cancer Res 1987, 47: 4361-5.
9. Dairkee, S.H., Deng, G., Stampfer, M.R., Waldman, F.M., Smith, H.S. Selective cell culture of primary breast carcinoma. Cancer Res 1995, 55: 2516-9.
10. Kawakami, M., Koya, K., Ukai, T., Tatsuta, N., Ikegawa, A., Ogawa, K., Shishido, T., Chen, L.B. Synthesis and evaluation of novel rhodacyanine dyes that exhibit antitumor activity. J Med Chem 1997, 40:3151-60.
11. Modica-Napolitano, J.S., Koya, K., Weisberg, E., Brunelli, B.T., Li, Y., Chen, L.B. Selective damage to carcinoma mitochondria by the rhodacyanine MKT-077. Cancer Res 1996, 56: 544-50.
12. Kubota, T., Chiba, Y., Ishizuka, H., Otani, Y., Watanabe, M., Kitajima, M., Matsumoto, Y., Koya, K. Antitumor activity of MKT-077, a delocalized lipophilic cation against human tumor cells in vitro. Proc Amer Assoc Cancer Res 1997, 38: Abst 1463.
13. Nalin, C.M., Schofield, L.J., Newman, M.J., Bair, K.W. Cytotoxicity of the chemotherapeutic drug SDZ MKT 077 against human tumor cell lines in vitro. Proc Amer Assoc Cancer Res 1997, 38: Abst 2064.
14. Shankar Narayan, K., Carl, J., Arcadi, J.A., Jones, L.W. Comparative cytotoxicity of rhodamine 123 and MKT-077 on prostate cancer and non-tumorigenic cells in vitro. Proc Amer Assoc Cancer Res 1997, 38: Abst 1480.
15. Chiba, Y., Kubota, T., Ishizuka, H., Watanabe, M., Teramoto, T., Kitajima, M., Matsumoto, Y., Koya, K. Antitumor activity of MKT-077, a delocalized lipophilic cation against human tumor cells in vivo. Proc Amer Assoc Cancer Res 1997, 38: Abst 1464.
16. Weisberg, E.L., Koya, K., Modica-Napolitano, J., Li, Y., Chen, L.B. In vivo administration of MKT-077 causes partial yet reversible impairment of mitochondrial function. Cancer Res 1996, 56: 551-5.
17. Kawakami, M., Koya, K., Tatsuta, N., Ikegawa, A., Shishido, T. Structure-activity relationships of novel antitumor agent MKT 077 and its related compounds. 17th Symp Med Chem/6th Annu Meet Div Med Chem/2nd Conf Drug Discov (Nov 19-21, Tsukuba) 1997, Abst 2-P-07.
18. Koya, K., Li, Y., Wang, H., Ukai, T., Tatsuta, N., Kawakami, M., Shishido, T., Chen, L.B. MKT-077, a novel rhodacyanine dye in clinical trials, exhibits anticarcinoma activity in preclinical studies based on selective mitochondria! accumulation. Cancer Res 1996, 56: 538-43.
19. Kubota, T., Chiba, Y., Matsuzaki, S., Hoshiya, Y., Nishibori, H., Watanabe, M., Teramoto, T., Kitajima, M., Matsumoto, Y., Koya, K.Antitumor activity of MKT-077, a delocalized lipophilic cation against human tumor cells (I). 55th Annu Meet Jpn Cancer Assoc (Oct 10-12, Yokohama) 1996, Abst 698.
20. Chiba, Y., Kubota, T., Watanabe, M., Matsuzaki, S.W., Otani, Y., Teramoto, T., Kitajima, M., Matsumoto, Y., Koya, K. Antitumor activity of a delocalized lipophilic cation, MKT-077 (II). 56th Annu Meet Jpn Soc Cancer Res (Sept 25-27, Kyoto) 1997, Abst NDO-01.
21. Kubota, T., Chiba, Y., Watanabe, M., Matsuzaki, S.W., Otani, Y., Teramoto, T., Kitajima, M., Matsumoto, Y., Koya, K. A delocalized lipophilic cation, MKT-077 (I). 56th Annu Meet Jpn Soc Cancer Res (Sept 25-27, Kyoto) 1997, Abst NDO-03.
22. Chiba, Y., Kubota, T., Matsuzaki, S., Hoshiya, Y., Nishibori, H., Watanabe, M., Teramoto, T., Kitajima, M., Matsumoto, Y., Koya, K. Antitumor activity of MKT-077, a delocalized lipophilic cation against human tumor cells (II). 55th Annu Meet Jpn Cancer Assoc (Oct 10-12, Yokohama) 1996, Abst 2527.